CAMBRIDGE, Mass., Sept. 7 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals
Incorporated (Nasdaq: VRTX) will webcast its presentations at BioCentury's
NewsMakers in the Biotech Industry Conference on September 9, 2005 and at Bear
Stearns' 18th Annual Healthcare Conference on September 13, 2005. Joshua
Boger, Ph.D., Chairman, President and Chief Executive Officer of Vertex will
present at both conferences and will provide an overview of Vertex and review
the Company's goals.
Vertex's presentation at BioCentury's NewsMakers in the Biotech Industry
Conference will be webcast on Friday, September 9, 2005 at 11:30 a.m. EDT.
Vertex's presentation at Bear Stearns' 18th Annual Healthcare Conference will
be webcast on Tuesday, September 13, 2005 at 10:30 a.m. EDT.
The presentations will be webcast live and may be accessed by visiting the
Vertex website at http://www.vrtx.com. A replay of the webcasts will also be
available on the Company's website for two weeks following the presentations.
To access the webcasts, go to Vertex's website and select the 'BioCentury
NewsMakers in the Biotech Industry' or the 'Bear Stearns 18th Annual
Healthcare' conferences from the 'Events Calendar.' To ensure a timely
connection, it is recommended that users register at least 15 minutes prior to
the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral diseases,
inflammation, autoimmune diseases and cancer. In collaboration with
GlaxoSmithKline, Vertex co-promotes the HIV protease inhibitor, Lexiva(R).
Lexiva(R) is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
Company News On-Call:
http://www.prnewswire.com/comp/938395.html
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex Pharmaceuticals Incorporated, +1-617-444-6755
|
